| Celebrex
& Arthritis Facts
- Over 43 million
people suffer from some form of arthritis,
including some 300,000 children;
- About 1.3 billion drugs were prescribed in 2002;
- Doctors write more than 350,000 prescriptions for Celebrex each week.
- Canadian health officials have linked Celebrex to atleast 14 deaths,
numerous heart and brain related side effects;
- Pfizer, Inc. reported a 49% earnings growth for the third quarter 2004,
primarily due to robust sales for Celebrex;
- Sales of Celebrex and
Bextra, another treatment for arthritis pain, surged
in the third quarter 2004, with Celebrex rising 14
percent to $797 million and Bextra climbing 37 percent
to $324 million.
- Celebrex patients, and their health insurance providers, spend upwards
of $2/day per patient for Celebrex prescriptions.
- NSAID prescription costs hit a record $6.5 billion in 2003;
- In the first three months following Celebrex's release on the market,
The Wall Street Journal linked 10 deaths to the NSAID.
In addition, there were eleven other cases of
gastrointestinal hemorrhage associated with the drug.
- Since 1998 more than 20 million arthritis patients have been prescribed
Celebrex.
- Due in part to the
aggressive marketing practices of pharmaceutical
manufacturers, 10% more patients in 2003 asked their
doctor about a specific arthritis drug, like Celebrex, compared to
2002.
Drug litigation can be extremely
complex. It is best to seek the counsel of a
personal injury attorney with experience in this
field of law. Belluck & Fox has substantial
experience with defective product litigation,
including pharmaceutical and medical product cases.
FREE ONLINE CELEBREX CASE
EVALUATION
Belluck & Fox,
LLP, is located in the heart of New York City, on
Madison Avenue. Call us today, toll free, at
1-877-NYLAW09 or contact
us via our online form.
Back
to Top
|
